Metabolomics

Dataset Information

0

TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes (part-I)


ABSTRACT: Mitochondrial trifunctional protein deficiency, due to mutations in hydratase subunit A (HADHA), results in sudden infant death syndrome (SIDS) with no cure. To reveal the disease etiology, we generated stem cell-derived cardiomyocytes from HADHA-deficient hiPSCs and accelerated their maturation via a novel, engineered MicroRNA Maturation Cocktail (MiMaC) that upregulated the epigenetic regulator, HOPX. Fatty acid challenged MiMaC treated HADHA mutant cardiomyocytes manifested the disease phenotype: defective calcium dynamics and repolarization kinetics which resulted in a pro-arrhythmic state. Single cell RNA-seq revealed a novel cardiomyocyte developmental intermediate, based on metabolic gene expression. This intermediate gave rise to mature-like cardiomyocytes in control cells but, mutant cells transitioned to a pathological state with reduced fatty acid beta-oxidation (FAO), reduced mitochondrial proton gradient, disrupted cristae structure and defective cardiolipin remodeling. This study reveals that TFPa/HADHA, a MLCL-AT-like enzyme, is required for FAO and cardiolipin remodeling, essential for functional mitochondria in human cardiomyocytes.

ORGANISM(S): Human Homo Sapiens

TISSUE(S): Cultured Cells

DISEASE(S): Sudden Infant Death Syndrome

SUBMITTER: Megan Showalter  

PROVIDER: ST001246 | MetabolomicsWorkbench | Mon Aug 26 00:00:00 BST 2019

REPOSITORIES: MetabolomicsWorkbench

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-08-25 | GSE135595 | GEO
2018-09-12 | GSE119775 | GEO
2023-07-15 | GSE221663 | GEO
2023-07-15 | GSE221662 | GEO
2023-06-07 | MSV000092116 | MassIVE
2020-07-08 | GSE148178 | GEO
2023-08-01 | GSE215056 | GEO
| PRJNA490270 | ENA
2023-03-06 | PXD029861 | Pride
2018-07-19 | GSE110297 | GEO